Biotechnology
Mylan Inc. today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., to resolve the parties' patent litigation relating to Sunovion's Brovana® ...
3 days ago
Manny Villafana, Chairman and CEO of Kips Bay Medical Inc. announced that Prof. Michele Genoni, MD, Chief of Cardiovascular Surgery of the Triemli Hospital, Zurich, Switzerland will be presenting his center's early clinical experience with the eSVS ...
3 days ago
Biotechnology Industry Organization President and CEO Jim Greenwood issued the following statement in support of the U.S. Senate's approval of the Food and Drug Administration Safety and Innovation Act :
3 days ago
With approximately one in four adults suffering from a diagnosable mental health disorder, coupled with restrictive funding and high case loads, the value of independent living centers providing peer-to-peer counseling is vital to effective mental ...
3 days ago
Health Canada, the Federal department responsible for helping Canadians maintain and improve their health, has authorized for marketing a new source plasma collection system developed by Fenwal Inc. Called the Aurora plasmapheresis system, the new ...
3 days ago
Synthetic Genomics Inc. , a privately held company commercializing and developing genomic-driven solutions to solve a range of global challenges, today announced they have purchased an 81 acre site for scale up and testing of newly identified and ...
3 days ago
The Biotechnology Industry Organization applauds Senator Robert Menendez for introducing the 'The Extension of the Therapeutic Discovery Project Tax Credit' , which will extend and improve the critical TDP program to support breakthrough medical ...
3 days ago
Biostem U.S., Corporation, , a fully reporting public company in the stem cell regenerative medicine sciences sector, announces a $5,000,000 financing agreement through private placement of stock.
3 days ago
Altogen Labs CRO, a preclinical contract research laboratory, announced its launch of microorganism ID bacteria identification service today. Microorganism identification and bioinformatic sequence characterization services are available for all ...
3 days ago
The X PRIZE Foundation and Nokia today announced the launch of the Nokia Sensing X CHALLENGE, a $2.25 million global competition to stimulate the development of a new generation of health sensors and sensing technologies that can drastically ...
3 days ago
True Diagnostics, Inc.™ has announced it has received a CE Mark to allow it to distribute its TrueDX Platform and quantitative TSH test in Europe. With the TrueDX Platform, doctors can immediately determine if a patient suffers from a ...
4 days ago
Sangart, Inc., a global biopharmaceutical company dedicated to developing and commercializing targeted rescue therapies for patients in acute ischemic crisis, today announced that it recently received $50 million in additional equity funding from ...
4 days ago
For years, doctors and microbiologists have sent out biopsies, slides, X-rays and other information outside the body for examination. These tests take days to get back and cannot be used immediately or during procedures. Donald Spector, a well-...
4 days ago
Questcor Pharmaceuticals, Inc. announced today that executive management will present at the Jefferies 2012 Global Healthcare Conference in New York on June 6, 2012 at 5:00 a.m. PT / 8:00 a.m. ET.
4 days ago
GE Healthcare and Royal Philips Electronics applaud the Federal Communications Commission today for its action allocating protected spectrum for wireless medical devices, called Medical Body Area Networks , which could revolutionize the way ...
4 days ago
NeuroMetrix, Inc. , www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that it has engaged IRG, LLC , a prominent, full service corporate communications ...
4 days ago
RetroSense Therapeutics, a gene therapy company dedicated to vision restoration, announced completion of a pre-IND meeting with the Center for Biological Evaluation and Research division of the FDA that took place on May 22nd 2012 regarding ...
4 days ago
Dyax Corp. the manufacturer of KALBITOR for the treatment of acute attacks of hereditary angioedema in patients 16 years of age and older, has announced the launch of its HAE diagnostic testing refund program. The program is designed to help ...
4 days ago
Dynasil Corporation of America today announced that it has entered into a technology collaboration agreement with Mayo Clinic, a not-for-profit worldwide leader in medical care, research and education for people from all walks of life. The first ...
4 days ago
Bristol-Myers Squibb Company will take part in Sanford Bernstein's 28th Annual Strategic Decisions Conference on Thursday, May 31, 2012, in New York. Lamberto Andreotti, chief executive officer, will answer questions about the company at 9 a.m. EST.
4 days ago
41 - 60 of 52903 Stories
<<
<
Next 20 Biotechnology
>
>>
Search News
